Abstract
The coronavirus disease 19 (COVID-19) is a highly pathogenic and transmissible viral disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which originated in the city of Wuhan, Hubei Province, Central China and spread quickly around the world. The genome sequence of SARSCoV- 2 is phylogenetically related to bat-derived severe acute respiratory syndrome-like (SARS-like) coronaviruses; therefore bats could be the possible primary reservoirs. At present, there are no clinically approved vaccines or specific antiviral drugs for COVID- 19. However, several broad-spectrum antiviral drugs have been evaluated against COVID-19 in clinical studies and resulted in the improvement of patients. In this regard, other therapies such as antiviral drugs, antibodies, stem cells and plasma therapy are being studied. In the current study, we reviewed the emergence, pathogenicity and the genome structure of COVID-19 infection. The main focus of this study is on the therapeutic approaches that may be effective against SARS-CoV-2.
Keywords: COVID-19, novel coronavirus, therapeutic, SARS-CoV-2, antiviral, SARS-CoV-19.
Current Molecular Medicine
Title:Therapeutic Measures for the Novel Coronavirus: A Review of Current Status and Future Perspective
Volume: 21 Issue: 7
Author(s): Mahshid Shahverdi and Maryam Darvish*
Affiliation:
- Department of Medical Biotechnology, School of Medicine, Arak University of Medical Sciences, Arak,Iran
Keywords: COVID-19, novel coronavirus, therapeutic, SARS-CoV-2, antiviral, SARS-CoV-19.
Abstract: The coronavirus disease 19 (COVID-19) is a highly pathogenic and transmissible viral disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which originated in the city of Wuhan, Hubei Province, Central China and spread quickly around the world. The genome sequence of SARSCoV- 2 is phylogenetically related to bat-derived severe acute respiratory syndrome-like (SARS-like) coronaviruses; therefore bats could be the possible primary reservoirs. At present, there are no clinically approved vaccines or specific antiviral drugs for COVID- 19. However, several broad-spectrum antiviral drugs have been evaluated against COVID-19 in clinical studies and resulted in the improvement of patients. In this regard, other therapies such as antiviral drugs, antibodies, stem cells and plasma therapy are being studied. In the current study, we reviewed the emergence, pathogenicity and the genome structure of COVID-19 infection. The main focus of this study is on the therapeutic approaches that may be effective against SARS-CoV-2.
Export Options
About this article
Cite this article as:
Shahverdi Mahshid and Darvish Maryam *, Therapeutic Measures for the Novel Coronavirus: A Review of Current Status and Future Perspective, Current Molecular Medicine 2021; 21 (7) . https://dx.doi.org/10.2174/1566524020666201203170230
DOI https://dx.doi.org/10.2174/1566524020666201203170230 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Computer-aided Design of Coumarins for Neurodegenerative Diseases: Trends of the Last Decade
Current Topics in Medicinal Chemistry The Review of the Synthesis of Bestatin, an Effective Inhibitor of Aminopeptidase N
Mini-Reviews in Organic Chemistry SARS-CoV-2: Origin, Pathogenesis and Therapeutic Interventions
Coronaviruses Computer Aided Drug Design Studies in the Discovery of Secondary Metabolites Targeted Against Age-Related Neurodegenerative Diseases
Current Topics in Medicinal Chemistry Viral Infection - A Cure for Type 1 Diabetes?
Current Medicinal Chemistry <i>In Silico</i> Screening of Some Anti-Cancer Drugs Against the Main Protease of COVID-19 Using Molecular Docking
Letters in Organic Chemistry Synthesis and Urease Inhibitory Properties of Some New N4-Substituted 5-Nitroisatin-3-thiosemicarbazones
Letters in Drug Design & Discovery Recent Advances in Pulmonary Hypertension Therapy
Recent Patents on Cardiovascular Drug Discovery Impact of “Long Covid” on Children: Global and Hong Kong Perspectives
Current Pediatric Reviews Matrix Metalloproteinases: New Routes to the Use of MT1-MMP As A Therapeutic Target in Angiogenesis-Related Disease
Current Pharmaceutical Design Target Based Drug Design - A Reality in Virtual Sphere
Current Medicinal Chemistry Global Gene Expression in Classification, Pathogenetic Understanding and Identification of Therapeutic Targets in Acute Myeloid Leukemia
Current Pharmaceutical Biotechnology Advances of AKT Pathway in Human Oncogenesis and as a Target for Anti-Cancer Drug Discovery
Current Cancer Drug Targets Therapeutic Effects of Physical Exercise and the Mesenchymal Stem Cell Secretome by Modulating Neuroinflammatory Response in Multiple Sclerosis
Current Stem Cell Research & Therapy Review on the Importance of Chitosan in Different Pharmaceutical Applications
Current Applied Polymer Science Structure-Activity Relationships of Selective GABA Uptake Inhibitors
Current Topics in Medicinal Chemistry Meet the Editorial Board Member
Current Drug Therapy Poly(ADP-Ribose) Polymerase Inhibitors: New Pharmacological Functions and Potential Clinical Implications
Current Pharmaceutical Design Thiophene and Its Analogs as Prospective Antioxidant Agents: A Retrospective Study
Mini-Reviews in Medicinal Chemistry Assessment of Burnout Levels Before and During COVID-19 Pandemic: A Web-Based Survey by the (Italian) Association of Medical Endocrinologists (AME)
Endocrine, Metabolic & Immune Disorders - Drug Targets